10206 related articles for article (PubMed ID: 1394334)
1. Penetration of anti-melanoma immunotoxin into multicellular tumor spheroids and cell kill effects.
Kikuchi T; Ohnuma T; Holland JF; Spitler LE
Cancer Immunol Immunother; 1992; 35(5):302-6. PubMed ID: 1394334
[TBL] [Abstract][Full Text] [Related]
2. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
[TBL] [Abstract][Full Text] [Related]
3. Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells.
Wargalla UC; Reisfeld RA
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5146-50. PubMed ID: 2544891
[TBL] [Abstract][Full Text] [Related]
4. Humoral immune response to a ricin A chain immunotoxin in patients with metastatic melanoma.
Hertler AA; Spitler LE; Frankel AE
Cancer Drug Deliv; 1987; 4(4):245-53. PubMed ID: 3502618
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin.
Chignola R; Foroni R; Franceschi A; Pasti M; Candiani C; Anselmi C; Fracasso G; Tridente G; Colombatti M
Br J Cancer; 1995 Sep; 72(3):607-14. PubMed ID: 7669569
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model.
Chignola R; Foroni R; Candiani C; Franceschi A; Pasti M; Stevanoni G; Anselmi C; Tridente G; Colombatti M
Int J Cancer; 1994 Apr; 57(2):268-74. PubMed ID: 8157364
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy of solid tumor--effects of hyaluronidase on doxorubicin (DXR) penetration into multicellular tumor spheroids (MTS)].
Kohno N; Ichikawa G; Kawasaki K; Kawaida M; Ohnuma T
Gan To Kagaku Ryoho; 1992 Jul; 19(7):981-6. PubMed ID: 1626955
[TBL] [Abstract][Full Text] [Related]
8. Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.
Godal A; Fodstad O; Morgan AC; Pihl A
J Natl Cancer Inst; 1986 Dec; 77(6):1247-53. PubMed ID: 3491924
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia potentiates the activity of immunotoxin conjugates against common acute lymphoblastic leukaemia cells in vitro.
Herrmann RP; Pelham JM; Raphael CL; Meyer BF; Davis RE
Ann N Y Acad Sci; 1987; 511():428-35. PubMed ID: 2964219
[TBL] [Abstract][Full Text] [Related]
10. An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancer.
Derbyshire EJ; Wawrzynczak EJ
Int J Cancer; 1992 Oct; 52(4):624-30. PubMed ID: 1328073
[TBL] [Abstract][Full Text] [Related]
11. Effects of hyaluronidase on doxorubicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality.
Kohno N; Ohnuma T; Truog P
J Cancer Res Clin Oncol; 1994; 120(5):293-7. PubMed ID: 8126058
[TBL] [Abstract][Full Text] [Related]
12. Effects of doxorubicin and cisplatin on multicellular tumor spheroids from human lung cancer.
Inoue S; Ohnuma T; Takaoka K; Suzuki Y; Kaneko M; Safirstein R; Holland JF
Cancer Drug Deliv; 1987; 4(4):213-24. PubMed ID: 3454248
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and properties of CD5-ricin immunotoxin].
Vikha GV; Uzhinova LD; Kashaeva AZh; Goshev VV; Krylov AV; Baryshnikov AIu; Vasilov RG
Biull Eksp Biol Med; 1995 Jan; 119(1):76-9. PubMed ID: 7536484
[No Abstract] [Full Text] [Related]
14. Internalization of the cytotoxic molecules of T101 F(ab')2-(ricin-A-chain) immunotoxin into human T-leukemic cells.
Ravel S; Casellas P
Eur J Biochem; 1990 Sep; 192(2):469-73. PubMed ID: 2209602
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.
Derbyshire EJ; Stahel RA; Wawrzynczak EJ
Cancer Immunol Immunother; 1992; 35(6):417-20. PubMed ID: 1327529
[TBL] [Abstract][Full Text] [Related]
16. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins.
Till M; May RD; Uhr JW; Thorpe PE; Vitetta ES
Cancer Res; 1988 Mar; 48(5):1119-23. PubMed ID: 3257712
[TBL] [Abstract][Full Text] [Related]
17. Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins.
Cumber AJ; Westwood JH; Henry RV; Parnell GD; Coles BF; Wawrzynczak EJ
Bioconjug Chem; 1992; 3(5):397-401. PubMed ID: 1329989
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
19. Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function.
Rasmussen RA; Counts SL; Lambert JM; Collinson AR
Cancer Immunol Immunother; 1992; 35(5):355-63. PubMed ID: 1394340
[TBL] [Abstract][Full Text] [Related]
20. Induction and increase of HLA-DR antigen expression by immune interferon on ML-3 cell line enhances the anti-HLA-DR immunotoxin activity.
Chiron M; Jaffrezou JP; Carayon P; Bordier C; Roubinet F; Xavier C; Brandely M; Laurent G
Clin Exp Immunol; 1990 Nov; 82(2):214-20. PubMed ID: 2122930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
